The OrganAge blood test introduces three transformative capabilities for precision medicine. First, it measures aging across 11 distinct organ systems using protein biomarkers, providing comprehensive biological aging profiles rather than relying on chronological age alone. Second, this approach predicts disease risk 20-50% more accurately than traditional assessment methods, enabling clinicians to identify vulnerable patients with far greater precision.
Most importantly, the test offers potential prevention decades before symptoms appear—a paradigm shift in medical practice. Instead of waiting for disease manifestation, physicians can now identify accelerated aging in specific organs and implement targeted interventions. This Stanford Medicine research, conducted on over 45,000 participants, demonstrates that biological age varies significantly across organ systems within individual patients. Understanding these variations allows for personalized prevention strategies that address specific vulnerabilities, potentially preventing disease progression before it begins. This represents a significant advancement in preventive medicine practice.
Read the full article on GMJ Newsroom.
Was this article helpful?
